Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (181-190 of 560) with videos related to

Pageof 56
Sort By:
Human Pathology|April 22, 2021
Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomasNa Niu, Weiwei Shen, Yanping Zhong, et al.
Gynecologic Oncology|April 1, 1994
Transfection of ovarian cancer cells with tumor necrosis factor-alpha (TNF-alpha) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-alphaS Wu, W A Meeker, J R Wiener, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanismsX F Le, A McWatters, J Wiener, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase AX Fang, S X Yu, Y Lu, et al.
Obstetrics and Gynecology|September 11, 1990
Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vaginaA Berchuck, G Rodriguez, A Kamel, et al.
Leukemia Research|January 1, 1986
Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complementP De Fabritiis, M Bregni, J Lipton, et al.
Obstetrics and Gynecology|February 1, 1990
Preoperative serum tumor-associated antigen levels in women with pelvic massesJ T Soper, V J Hunter, L Daly, et al.
Cancer|July 1, 2011
Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialLee E Moore, Ruth M Pfeiffer, Zhen Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse modelJ R Wiener, K Nakano, R P Kruzelock, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
Pageof 56

Showing results (181-190 of 560) with videos related to

Sort By:
Pageof 56
Human Pathology|April 22, 2021
Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomasNa Niu, Weiwei Shen, Yanping Zhong, et al.
Gynecologic Oncology|April 1, 1994
Transfection of ovarian cancer cells with tumor necrosis factor-alpha (TNF-alpha) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-alphaS Wu, W A Meeker, J R Wiener, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanismsX F Le, A McWatters, J Wiener, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2000
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase AX Fang, S X Yu, Y Lu, et al.
Obstetrics and Gynecology|September 11, 1990
Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vaginaA Berchuck, G Rodriguez, A Kamel, et al.
Leukemia Research|January 1, 1986
Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complementP De Fabritiis, M Bregni, J Lipton, et al.
Obstetrics and Gynecology|February 1, 1990
Preoperative serum tumor-associated antigen levels in women with pelvic massesJ T Soper, V J Hunter, L Daly, et al.
Cancer|July 1, 2011
Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialLee E Moore, Ruth M Pfeiffer, Zhen Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse modelJ R Wiener, K Nakano, R P Kruzelock, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cellsA Elbendary, A Berchuck, P Davis, et al.
Pageof 56